Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Completed NCT07772583

THE EFFECT OF MUSİC THERAPY IN HEMODİALYSİS PATİENTS

Conditions: Hemodialysis, Pain, Anxiety, Stress

Sex: All
Ages: 18 Years – N/A
Healthy volunteers: Yes
Phase: NA
Enrollment: 68
Sponsor: Izmir Tinaztepe University

Location: Daviva Goztepe Dialysis Center Izmir

Summary

The aim of this study is to evaluate the effects of music therapy on pain intensity, anxiety levels, and hemodynamics (vital signs) in end-stage renal disease (ESRD) patients undergoing maintenance hemodialysis. This study employs a quasi-experimental design with a pretest-posttest control group, conducted among patients receiving routine hemodialysis treatment at the DaViVa Göztepe Dialysis Center. Participants in the intervention group receive music therapy applied in 30-minute sessions at the beginning of each hour throughout their hemodialysis treatments (specifically during vascular access/cannulation and dialytic sessions), while the control group receives standard nursing care. Objective physiological parameters along with validated subjective pain and anxiety scales are measured before and after the intervention to determine the therapeutic efficacy of music as a non-pharmacological nursing intervention.

Eligibility Criteria

Inclusion Criteria:Registered at the Daviva Göztepe Dialysis Center, Aged 18 years and older, Receiving hemodialysis (HD) treatment for at least 6 months, Scheduled for HD treatment 3 days a week, Free of hearing impairment, Voluntarily agreeing to participate in the study. - Exclusion Criteria:Having a psychiatric diagnosis or hemodynamically unstable condition, Engaging in another complementary and integrative therapy, Unwilling to participate in the study. \-

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT07772583). StuddyBuddy aggregates publicly available trial information.